Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
18 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
PHARMACIE RENARD from Ciney, company number BE0479272941, closed financial year 2025 with a result of € 147,929 after tax. For that financial year PHARMACIE RENARD recorded a gross margin of € 792,295 and equity of € 1.1 million. Compared with financial year 2024, the result moved from € 148,605 to € 147,929. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2026.
€ 1.1 million
▲ 2% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 147,929
Profit after tax over the fiscal year.
€ 429,721
▲ 66% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 125,500 paid out
85 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
8
▼ 0.3 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 480,142
▼ 1% vs 2024
€ 60,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 54,389
▼ 36% vs 2024
Of which on lease € 34,352.
Debts at end 2025
€ 22,028
▼ 49% vs 2024
Loans from banks and other lenders, long and short.
€ 243,276
▲ 25% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 80,382
▲ 31% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 848,664 | € 809,092 | € 803,059 | € 792,295 | ▼ 1% |
| Profit after taxes | € 259,977 | € 191,346 | € 148,605 | € 147,929 | |
| Equity | € 970,748 | € 1,000,844 | € 1,110,997 | € 1,133,425 | ▲ 2% |
| Total debts | € 558,507 | € 409,381 | € 298,848 | € 345,685 | ▲ 16% |
| Cash | € 293,216 | € 242,763 | € 258,994 | € 429,721 | ▲ 66% |
| Land & buildings | € 300,831 | € 276,007 | € 255,018 | € 236,872 | ▼ 7% |
| Retained profit | € 964,548 | € 994,644 | € 1,104,797 | € 1,127,225 | ▲ 2% |
| Dividend | € 0 | € 161,250 | € 38,452 | € 125,500 | ▲ 226% |
| Bank debt | € 0 | € 75,349 | € 43,266 | € 22,028 | ▼ 49% |
| Balance sheet total | € 1,529,255 | € 1,410,225 | € 1,409,845 | € 1,479,111 | ▲ 5% |
| Employees (FTE) | 9.2 | 8.8 | 8.3 | 8 | ▼ 0.3 |
Key figures of PHARMACIE RENARD, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE RENARD?
What happened at PHARMACIE RENARD in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Pascal Peeters stepped down as director. NBB
- Régis Lanove stepped down as director. NBB
- Thibaut De Haes stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 147,929. filed late Source: NBB ↗
- Pascal Peeters became a director. NBB
- Régis Lanove became a director. NBB
- Thibaut De Haes became a director. NBB
- ANNE THAUVIN stepped down as director. NBB
In short
From € 259,977 profit in 2022 to € 147,929 profit in 2025.
Paid € 313,727 in corporate taxes since 2022.
Best year ever: 2022, with € 259,977 profit.
On average € 99,000 of value added per employee in 2025.
A new publication or filing at PHARMACIE RENARD? We notify you, reason included.
Follow PHARMACIE RENARDDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2025 annual accounts
Pascal Peeters
Director
since 2026 · until 2032
Régis Lanove
Director
since 2026 · until 2032
Thibaut De Haes
Director
since 2026 · until 2032
since 2023 · until 2026
since 2023 · until 2026
Establishments
Establishment units
Physical locations of this company
Rue Edouard Dinot 32
5590 Ciney
Place du Centre(NAL) 3
6120 Ham-sur-Heure-Nalinnes
Active since 4 March 2003
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 18 companies are registered at this address.
All companies at this address →L'Economie Populaire
€ 172.9 million revenue · 2025
Familia Real Estate
Respectable Vehicle Collectors Club
Pharmacie de la Semois
€ 261,046 gross margin · 2025
PHARMACIE SANTIS DES CORETTES
€ 288,944 gross margin · 2025
+13 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0479.272.941
- VAT number
- BE 0479.272.941
- Registered office
- Rue Edouard Dinot 32, 5590 Ciney
- Names & denominations
- PHARMACIE RENARD
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 13 January 2003
- Peppol
- Active · Active since 17 Jul 2026
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels